Cited by

• PPAR-α Modulators as Current and Potential Cancer Treatments.

  Tan Y, Wang M, Yang K, Chi T, Liao Z, Wei P. Tan Y, et al. Front Oncol. 2021 Mar 23;11:599995. doi: 10.3389/fonc.2021.599995. eCollection 2021. Front Oncol. 2021. PMID: 33833983 Free PMC article. Review.
• Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.

  van der Sligte NE, Kampen KR, ter Elst A, Scherpen FJ, Meeuwsen-de Boer TG, Guryev V, van Leeuwen FN, Kornblau SM, de Bont ES. van der Sligte NE, et al. Oncotarget. 2015 Jun 20;6(17):14970-81. doi: 10.18632/oncotarget.3911. Oncotarget. 2015. PMID: 26008971 Free PMC article.
• Bladder cancer biomarker discovery using global metabolomic profiling of urine.

  Wittmann BM, Stirdivant SM, Mitchell MW, Wulff JE, McDunn JE, Li Z, Dennis-Barrie A, Neri BP, Milburn MV, Lotan Y, Wolfert RL. Wittmann BM, et al. PLoS One. 2014 Dec 26;9(12):e115870. doi: 10.1371/journal.pone.0115870. eCollection 2014. PLoS One. 2014. PMID: 25541698 Free PMC article.
• The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.

  Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CM. Tili E, et al. Blood. 2012 Sep 27;120(13):2631-8. doi: 10.1182/blood-2012-03-415737. Epub 2012 Jun 21. Blood. 2012. PMID: 22723551 Free PMC article.
• Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

  Shetzer Y, Molchadsky A, Rotter V. Shetzer Y, et al. Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):a026203. doi: 10.1101/cshperspect.a026203. Cold Spring Harb Perspect Med. 2016. PMID: 27235476 Free PMC article. Review.